Biological Sciences Division
Published August 22, 2019 | Version v1
Patent Open

METHODS OF TREATING CASTRATION-RESISTANT PROSTATE CANCER WITH GLUCOCORTICOID RECEPTOR ANTAGONISTS

Creators

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Embodiments of the invention are directed to the treatment of subjects with prostate cancer, in particular those with castration resistant prostate cancer, with glucocorticoid receptor antagonists. The prostate cancer may be one that has become resistant to androgen deprivation therapy, for example, by increase in glucocorticoid receptor expression and/or activity.

Files

US20190255069.pdf

Files (1.3 MB)

Name Size Download all
md5:96021a3c969027f3d743c313d963a95b
1.3 MB Preview Download

Additional details

Identifiers

Patent application number
US 201916374157 A
Patent number
US 2019/0255069 A1
Other
oai:uchicago.tind.io:8028

Dates

Patent filed
2019-04-03

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine